Talphera, Inc. financial data

Symbol
TLPH on Nasdaq
Industry
Pharmaceutical Preparations
Location
1850 Gateway Drive, Suite 175, San Mateo, CA
Fiscal year end
December 31
Former names
ACELRX PHARMACEUTICALS INC (to 12/14/2023)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 479 % +99.8%
Debt-to-equity 98.9 % +84.4%
Return On Equity -111 % +13.6%
Return On Assets -56 % +33.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.1M shares +0.76%
Common Stock, Shares, Outstanding 17M shares +0.45%
Entity Public Float 13.2M USD +9.33%
Common Stock, Value, Issued 17K USD 0%
Weighted Average Number of Shares Outstanding, Basic 25.8M shares +81.2%
Weighted Average Number of Shares Outstanding, Diluted 14.3M shares +92.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 6.72M USD +21.1%
Costs and Expenses 15.3M USD -13%
Operating Income (Loss) -25.7M USD -84.7%
Nonoperating Income (Expense) 2.25M USD -66%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.35M USD -137%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -13M USD +29.3%
Earnings Per Share, Basic -0.5 USD/shares +61.2%
Earnings Per Share, Diluted -0.08 USD/shares +91.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.86M USD +54.9%
Cash, Cash Equivalents, and Short-term Investments 14M USD
Assets, Current 9.42M USD -18.7%
Operating Lease, Right-of-Use Asset 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 8.82M USD 0%
Other Assets, Noncurrent 20K USD -88%
Assets 18.2M USD -10.6%
Accounts Payable, Current 670K USD -49.9%
Accrued Liabilities, Current 1.25M USD -48.7%
Liabilities, Current 2.65M USD -41.3%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 10.2M USD +62.7%
Retained Earnings (Accumulated Deficit) -457M USD -2.93%
Stockholders' Equity Attributable to Parent 8M USD -43.3%
Liabilities and Equity 18.2M USD -10.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.88M USD +45.1%
Net Cash Provided by (Used in) Financing Activities 12M USD
Net Cash Provided by (Used in) Investing Activities -2.73M USD -783%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 17M shares +0.45%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.4M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.72M USD -71.8%
Deferred Tax Assets, Valuation Allowance 103M USD +2.86%
Deferred Tax Assets, Gross 105M USD +2.78%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Operating Lease, Liability, Current 51K USD -95.7%
Deferred Tax Assets, Operating Loss Carryforwards 90.1M USD +1.47%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 3.03M USD +6.91%
Additional Paid in Capital 465M USD +1.51%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 0 USD -100%
Share-based Payment Arrangement, Expense 989K USD -42.8%
Interest Expense 15K USD -98.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%